Axinn Veltrop Harkrider LLP
General
Cases244
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
BiotechMech Eng, ManufSemicond., Optic
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/16/24 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [398] Notice of Appeal (Federal Circuit) filed by AlterWAN, Inc.. USCA Case Number 2025-1285. (mdb) (Entered: 12/16/2024) | |
| 12/13/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2; 10,335,462 B2; 8,129,343 B2; 8,920,383 B2; 9,457,154 B2; 9,775,953 B2. (Attachments: # [1] Stipulation of Dismissal) (mws) (Entered: 12/13/2024) | |
| 12/13/24 | SO ORDERED, re (422 in 1:22-md-03038-CFC-EGT, 36 in 1:22-cv-00297-CFC, 371 in 1:22-cv-00294-CFC-EGT) Stipulation of Dismissal Among Novo Nordisk Inc., Novo Nordisk A/S, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences, filed by Novo Nordisk A/S, Novo Nordisk Inc. (Terminating Hearings: 12/16/2024 Bench Trial terminated.) Signed by Judge Colm F. Connolly on 12/13/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC, 1:22-md-03038-CFC-EGT(kmd) (Entered: 12/13/2024) | |
| 12/13/24 | Remark: CASE CLOSED per [371] STIPULATION of Dismissal, as all defendants in the case have been terminated. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-00297-CFC (mws) (Entered: 12/13/2024) | |
| 11/01/24 | PROPOSED CONSENT JUDGMENT as to Novugen Pharma Sdn. Bhd. and Novugen Pharma (USA) LLC by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 11/01/2024) | |
| 10/21/24 | Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for [200] Notice of Appeal to the Federal Circuit, filed by Regeneron Pharmaceuticals, Inc. were transmitted to the U.S. Court of Appeals. (km) (Entered: 10/21/2024) | |
| 10/21/24 | Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: [200] Notice of Appeal to the Federal Circuit.(km) (Entered: 10/21/2024) | |
| 10/08/24 | STIPULATION of Dismissal without prejudice as to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (C.A. No. 22-298) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) | |
| 10/08/24 | STIPULATION of Dismissal without prejudice as to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. (C.A. No. 22-296) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/08/2024) | |
| 09/16/24 | [SEALED] Letter to The Honorable Sherry R. Fallon from Karen E. Keller regarding Amendment of Defendants' Answer and Counterclaims. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8)(Keller, Karen) Modified on 9/16/2024 (lih). (Entered: 09/16/2024) |